Fibroblast growth factor 23 serum level in type 2 diabetic italian subjects with peripheral arterial disease and critical limb ischemia

被引：2
|
作者：
Biscetti, F. [1 ,2 ]
Straface, G. [3 ]
Pitocco, D. [4 ]
Angelini, F. [2 ]
Tinelli, G. [5 ]
Landolfi, R. [6 ]
Flex, A. [2 ,6 ]
机构：
[1] Univ Cattolica Sacro Cuore, Sch Med, Fdn A Gemelli Univ Hosp, Inst Rheumatol & Affine Sci, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Sch Med, Lab Vasc Biol & Genet, Rome, Italy
[3] St M Goretti Hosp, Dept Med, Latina, Italy
[4] Univ Cattolica Sacro Cuore, Sch Med, Fdn A Gemelli Univ Hosp, Diabet Care Unit,Dept Internal Med, Rome, Italy
[5] Univ Cattolica Sacro Cuore, Sch Med, Fdn A Gemelli Univ Hosp, Dept Vasc Surg, Rome, Italy
[6] Univ Cattolica Sacro Cuore, Sch Med, Fdn A Gemelli Univ Hosp, Dept Internal Med, Rome, Italy
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2016年 / 20卷 / 19期
关键词：
Type; 2; diabetes; Fibroblast growth factor 23; FGF-23; Osteoprotegerin; OPG; Peripheral artery disease; PAD; Critical limb ischemia; CLI; VASCULAR CALCIFICATION; CAROTID PLAQUE; OSTEOPROTEGERIN; MORTALITY; HEART; NEPHROPATHY; ASSOCIATION; METABOLISM; EXPRESSION; PROTEIN;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OBJECTIVE: Fibroblast growth factor 23 (FGF23) was demonstrated to be involved in the occurrence and development of cardiovascular disease (CVD). The aim of this study was to investigate the potential role of FGF23 on presence and severity of peripheral arterial disease (PAD) in type 2 diabetic patients. PATIENTS AND METHODS: In this study, we analyzed FGF23 serum levels in 413 type 2 diabetic patients with PAD and in 598 diabetic controls without lower limbs atherosclerosis. RESULTS: We found that FGF23 median serum levels were significantly higher in patients than in diabetic controls (69.3 (58.8-75.1) pg/mL in PAD and 42.98 (37.1-49.8) pg/mL in subjects without PAD (p < 0.001) and were significantly and independently associated with critical limb ischemia (CLI) [OR, 7.69 (2.64-16.31); p = 0.001]. CONCLUSIONS: We have found, for the first time, that FGF23 could be associated with presence and severity of PAD in Italian patients with type 2 diabetes.
引用
收藏
页码：4048 / 4054
页数：7
相关论文
共 50 条
  • [41] Clinical Applications for Radiotracer Imaging of Lower Extremity Peripheral Arterial Disease and Critical Limb Ischemia
    Chou, Ting-Heng
    Stacy, Mitchel R.
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (02) : 245 - 255
  • [42] Antiplatelet Therapy for Peripheral Arterial Disease and Critical Limb Ischemia: Guidelines Abound, But Where Are the Data?
    Azarbal, Amir
    Clavijo, Leonardo
    Gaglia, Michael A., Jr.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 20 (02) : 144 - 156
  • [43] Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia
    Tanaka, Kentaro
    Hara, Shigeko
    Kushiyama, Akifumi
    Ubara, Yoshifumi
    Yoshida, Yoko
    Mizuiri, Sonoo
    Aikawa, Atsushi
    Kawatzu, Shouji
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (03) : 391 - 397
  • [44] Serum Fibroblast Growth Factor 23 Level and Liver Fat Content in MAFLD: A Community-Based Cohort
    Cao, Weijie
    Xu, Yiting
    Shen, Yun
    Wang, Yufei
    Ma, Xiaojing
    Bao, Yuqian
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 4135 - 4143
  • [45] Higher level of serum vascular endothelial growth factor in type 2 diabetic patients with diabetic retinopathy hospitalized for hyperglycemic state
    Takamiya Y.
    Oikawa Y.
    Hirose H.
    Shimada A.
    Itoh H.
    Diabetology International, 2011, 2 (1) : 19 - 25
  • [46] Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes
    Bin Feng
    Guidong Xu
    Kangyun Sun
    Kaipeng Duan
    Bimin Shi
    Nannan Zhang
    Cardiovascular Diabetology, 19
  • [47] Serum fibroblast growth factor 23 for early detection of acute kidney injury in critical illness
    Sun, Shu
    Liu, Zhijia
    Chen, Changqing
    Wang, Zhisong
    Jin, Hailong
    Meng, Xiaoyun
    Dai, Bing
    Zhang, Liming
    Zhou, Chenchen
    Xue, Cheng
    Li, Xiang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (11): : 12141 - 12151
  • [48] Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
    Xiao, Yang
    Liu, Lingjiao
    Xu, Aimin
    Zhou, Pengcheng
    Long, Zhaofeng
    Tu, Yiting
    Chen, Xiaoyan
    Tang, Weili
    Huang, Gan
    Zhou, Zhiguang
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [49] Different Mid-Term Prognostic Predictors of Major Adverse Events in Diabetic and Nondiabetic Peripheral Artery Disease Presenting With Critical Limb Ischemia
    Liang, Kae-Woei
    Kuo, Hsun-Nan
    Lee, Wen-Lieng
    Liu, Tsun-Jui
    Lin, Wei-Wen
    Tsao, Chen-Rong
    Ting, Chih-Tai
    Wang, Kuo-Yang
    ANGIOLOGY, 2016, 67 (03) : 287 - 291
  • [50] Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients
    M. Inaba
    S. Okuno
    Y. Imanishi
    S. Yamada
    A. Shioi
    T. Yamakawa
    E. Ishimura
    Y. Nishizawa
    Osteoporosis International, 2006, 17 : 1506 - 1513
12345